These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 33973539)
1. Evaluation of systemic estrogen for preventing urinary tract infections in postmenopausal women. Fox KA; Lokken EM; Reed SD; Rahn DD Menopause; 2021 May; 28(7):836-844. PubMed ID: 33973539 [TBL] [Abstract][Full Text] [Related]
2. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Perrotta C; Aznar M; Mejia R; Albert X; Ng CW Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910 [TBL] [Abstract][Full Text] [Related]
3. Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial. Ferrante KL; Wasenda EJ; Jung CE; Adams-Piper ER; Lukacz ES Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):112-117. PubMed ID: 31232721 [TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
5. Feasibility and Research Insights From a Randomized Controlled Trial for Recurrent Urinary Tract Infection Prevention in Postmenopausal Women Using Vaginal Estrogen Therapy. Lenger SM; Chu CM; Ghetti C; Durkin MJ; Jennings Z; Sutcliffe S; Lowder JL Female Pelvic Med Reconstr Surg; 2022 Jun; 28(6):e163-e170. PubMed ID: 35421017 [TBL] [Abstract][Full Text] [Related]
6. Recurrent urinary tract infection management and prevention techniques among a population-based cohort of women. Gleicher S; Sebesta EM; Kaufman MR; Dmochowski RR; Reynolds WS Neurourol Urodyn; 2023 Nov; 42(8):1676-1685. PubMed ID: 37670465 [TBL] [Abstract][Full Text] [Related]
7. Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiome. Neugent ML; Kumar A; Hulyalkar NV; Lutz KC; Nguyen VH; Fuentes JL; Zhang C; Nguyen A; Sharon BM; Kuprasertkul A; Arute AP; Ebrahimzadeh T; Natesan N; Xing C; Shulaev V; Li Q; Zimmern PE; Palmer KL; De Nisco NJ Cell Rep Med; 2022 Oct; 3(10):100753. PubMed ID: 36182683 [TBL] [Abstract][Full Text] [Related]
8. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials. Chen YY; Su TH; Lau HH Int Urogynecol J; 2021 Jan; 32(1):17-25. PubMed ID: 32564121 [TBL] [Abstract][Full Text] [Related]
9. The etiology and management of recurrent urinary tract infections in postmenopausal women. Jung C; Brubaker L Climacteric; 2019 Jun; 22(3):242-249. PubMed ID: 30624087 [TBL] [Abstract][Full Text] [Related]
10. d-Mannose for Recurrent Urinary Tract Infection Prevention in Postmenopausal Women Using Vaginal Estrogen: A Randomized Controlled Trial. Lenger SM; Chu CM; Ghetti C; Durkin MJ; Jennings Z; Wan F; Sutcliffe S; Lowder JL Urogynecology (Phila); 2023 Mar; 29(3):367-377. PubMed ID: 36808931 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological Agents to Decrease New Episodes of Recurrent Lower Urinary Tract Infections in Postmenopausal Women. A Systematic Review. Dueñas-Garcia OF; Sullivan G; Hall CD; Flynn MK; OʼDell K Female Pelvic Med Reconstr Surg; 2016; 22(2):63-9. PubMed ID: 26825411 [TBL] [Abstract][Full Text] [Related]
12. Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause. Buck ES; Lukas VA; Rubin RS Urology; 2021 May; 151():31-36. PubMed ID: 32533967 [TBL] [Abstract][Full Text] [Related]
17. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Lenger SM; Bradley MS; Thomas DA; Bertolet MH; Lowder JL; Sutcliffe S Am J Obstet Gynecol; 2020 Aug; 223(2):265.e1-265.e13. PubMed ID: 32497610 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women. Tan-Kim J; Shah NM; Do D; Menefee SA Am J Obstet Gynecol; 2023 Aug; 229(2):143.e1-143.e9. PubMed ID: 37178856 [TBL] [Abstract][Full Text] [Related]
19. The effect of local estrogen therapy on the urinary microbiome composition of postmenopausal women with and without recurrent urinary tract infections. Anglim B; Phillips C; Shynlova O; Alarab M Int Urogynecol J; 2022 Aug; 33(8):2107-2117. PubMed ID: 34003309 [TBL] [Abstract][Full Text] [Related]
20. Urinary prostaglandin E2 as a biomarker for recurrent UTI in postmenopausal women. Ebrahimzadeh T; Kuprasertkul A; Neugent ML; Lutz KC; Fuentes JL; Gadhvi J; Khan F; Zhang C; Sharon BM; Orth K; Li Q; Zimmern PE; De Nisco NJ Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 33958485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]